What Is Attracting Investors to LYB?

We're taking a closer look at LyondellBasell Industries NV today, as the chatter surrounding the stock has increased notably in the last few weeks. Today, its shares moved 0.7% compared to 0.5% for the S&P 500. Increased investor interest and volatility surrounding the stock are not reason enough to buy in -- you should first perform your own due diligence. Here are some figures that can get you started:

  • LyondellBasell Industries N.V. is a chemical company incorporated in 2009 and headquartered in Houston, Texas

  • LYB has an average analyst rating of hold and is -26.41% away from its mean target price of $106.43 per share

  • Its trailing 12 month price to earnings (Eps) is $7.0 per share

  • LyondellBasell Industries has a trailing 12 month Price to Earnings (P/E) ratio of 11.2 while the S&P 500 average is 15.97

  • Its forward 12 month price to earnings (Eps) is $7.0 per share and its forward P/E ratio is 6.3

  • LYB has a Price to Earnings Growth ratio of 1.6, which shows the company is fairly valued compared to its earnings.

  • The company has a Price to Book (P/B) ratio of 3.0 in contrast to the S&P 500's average ratio of 2.95

  • LyondellBasell Industries is part of the Basic Materials sector, which has an average P/E ratio of 8.57 and an average P/B of 1.86

  • LyondellBasell Industries has on average reported free cash flows of $3,206,500,000.00 over the last four years, during which time they have grown by an an average of 75.1%

  • LYB's gross profit margins have averaged 15.9 % over the last four years, during which time they had a growth rate of 9.3 % and a coefficient of variability of 17.7 %.

At Market Interference, we believe in giving retail investors access to timely and accurate data to help inform their investment decisions. subscribe to our free newsletter today to keep track of each day's market movers!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.